APA (7th ed.) Citation

W, B., J, E., G, H., & K, H. (2025). Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: A systematic review. EClinicalMedicine, 82, 103148. https://doi.org/10.1016/j.eclinm.2025.103148

Chicago Style (17th ed.) Citation

W, Burman, Ellis J, Hale G, and Hill K. "Adequacy of Recommendations for Adverse Event Management in National and International Treatment Guidelines for Rifampicin-susceptible Tuberculosis: A Systematic Review." EClinicalMedicine 82 (2025): 103148. https://doi.org/10.1016/j.eclinm.2025.103148.

MLA (9th ed.) Citation

W, Burman, et al. "Adequacy of Recommendations for Adverse Event Management in National and International Treatment Guidelines for Rifampicin-susceptible Tuberculosis: A Systematic Review." EClinicalMedicine, vol. 82, 2025, p. 103148, https://doi.org/10.1016/j.eclinm.2025.103148.